Marco Cacciuttolo

Dr. Cacciuttolo is senior vice president of process and analytical development with responsibility for ensuring the quality and safety of Novavax’ vaccine candidates. He brings more than three decades of biochemical engineering experience to Novavax and has successfully developed commercial processes for many products.

Prior to joining Novavax in July 2020, Dr. Cacciuttolo served as head of manufacturing at Nosocomial Vaccine Corporation, chief operating officer at PathoVax LLC, and managing director of Batavia Biosciences. Earlier in his career, he held positions of increasing responsibility at MedImmune LLC, Medarex, Percivia LLC and Tetragenetics, Inc.

Dr. Cacciuttolo received a bachelor’s degree in biochemical engineering from Pontifical Catholic University of Valparaíso and a doctorate in biochemical engineering from the University of Maryland, Baltimore.